Prothrombin Time (PT) Assay Kit (One-Stage Method)

Cat. No.: P1522036
Disponível para encomenda
GRAU & PUREZA BioReagent ? BioReagent grade — tested suitable for life-science and molecular-biology use. Use for cell culture, assays, and biochemical work needing biological compatibility.
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
100T
P1522036-100T
Sob encomenda · 8–12 semanas
78,01€
Enter a quantity for the sizes you want to add.

Visão geral

Clotting time refers to the time required for venous blood to clot completely after being drawn from the body. It is a screening assay reflecting the activity of various coagulation factors in the intrinsic coagulation system. Prothrombin Time (PT) is determined by adding excess tissue thromboplastin and calcium ions to test plasma. Prothrombin is converted into thrombin, which further transforms fibrinogen into fibrin. The time required for platelet-poor plasma to coagulate is recorded, with the International Sensitivity Index (ISI) as the reference.

Prothrombin Time (PT) Assay Kit (One-stage Method) is used to measure prothrombin time in plasma from human and animal blood. It reflects not only the level of prothrombin but also the plasma concentrations of Factor V, Factor VII, Factor X and fibrinogen. This kit serves as a screening reagent kit for the extrinsic coagulation system. For Research Use Only. Not intended for clinical diagnosis or other applications.


Contents & Storage:

Item No.
Appearance
Components
50TStorage
P1522036ALiquid
Sodium Citrate Anticoagulant (109 mM)
20 mL2-8℃.
P1522036BLiquid
PT Thromboplastin Solution
15 mL2-8℃.

Materials to Be Prepared:

1. Sodium citrate anticoagulant blood collection tubes (optional), blood collection needles, tourniquets

2. Centrifuge, timer or stopwatch, water bath


Operating Procedures (For Reference Only):

1. Preparation of test plasma: Mix fresh venous blood sample with 109 mM sodium citrate anticoagulant at a ratio of 9:1, invert gently to homogenize. Centrifuge at 3000 r/min for 10–15 min. Collect the supernatant (platelet-poor plasma) and transfer into plastic test tubes or centrifuge tubes to avoid platelet activation. Normal control plasma shall be prepared in parallel.

2. Pipette 0.07 mL test plasma and 0.14 mL PT Thromboplastin Solution separately, incubate both at 37 °C water bath for 3 min.

3. Combine test plasma (including normal control plasma) with PT Thromboplastin Solution, start the stopwatch immediately. Tilt the tube gently and continuously. Record the time until the liquid stops flowing. Repeat the test 2–3 times and calculate the average value as Prothrombin Time (PT).

Prothrombin Time Ratio (PTR) = PT of test plasma / PT of normal reference plasma

International Normalized Ratio (INR) = PTRISI


Reference Intervals:

PT value (venous blood from healthy subjects): 10–14 s. A measured value ≥3 s longer than the normal control value is considered clinically significant. The above values are for reference only. Reference ranges may vary due to reagent batches, instruments, samples and operators. Each laboratory is recommended to establish its own reference interval.

ISI value: <2.0


Precautions:

1. A normal control sample must be tested simultaneously in all operations.

2. Plasma shall be collected using sodium citrate anticoagulant tubes. EDTA, heparin, oxalate and other anticoagulants are not allowed. Samples should be tested promptly after collection; storage at room temperature shall not exceed 1 h, and storage at 4 °C shall not exceed 4 h. Long-term low-temperature storage is generally not recommended.

3. Blood collection must use disposable plastic syringes or siliconized glass syringes. Blood storage must adopt plastic tubes or siliconized glass tubes. Ordinary glass containers shall not be used to prevent activation of coagulation factors.

4. Blood drawing should be smooth with sufficient anticoagulation. Avoid hemolysis and tissue contamination during sampling.

5. Plasma separation requires centrifugation above 3000 g for more than 10 min to ensure complete removal of platelets.

6. Plasma pre-incubation shall not exceed 5 min; pre-incubation of PT Thromboplastin Solution shall not exceed 15 min.

7. Incubation temperature shall be precisely controlled at 37±1 °C; either higher or lower temperature will prolong PT.

8. Sufficient light is required during operation. The endpoint of prothrombin time is defined as the initial visible turbidity and clot formation.

9. When hematocrit (Hct) is outside the range of 20–55%, the ratio between anticoagulant and blood shall be adjusted according to the formula below:

Anticoagulant volume (mL) = (100% − Hct) × Blood volume (mL) × 0.00185

10. This product is For Research Use Only. Not intended for clinical diagnosis or any other applications.

11. For your safety and health, wear a lab coat and disposable gloves during operation.


Especificações

Sinónimos
PT Detection Kit
Especificações e pureza
BioReagent
Grau
BioReagent
Aplicação
Tipo de amostra
Plasma
Quantitativo
Quantitative
Armazenamento e envio
Condições de armazenamento de armazenamento
Store at 2-8°C
Enviado em
Wet ice
Estabilidade e armazenamento
Store at 2-8℃ long term (6 months).
Contents & Storage
Item No.
Appearance
Components
50TStorage
P1522036ALiquid
Sodium Citrate Anticoagulant (109 mM)
20 mL2-8℃.
P1522036BLiquid
PT Thromboplastin Solution
15 mL2-8℃.

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDataItem
ZJ26F0838324ZJ26F0838324Certificate of AnalysisAug 12, 2026 P1522036
FAQs e artigos
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.